237 related articles for article (PubMed ID: 1693592)
1. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
Falini B; Pileri S; Stein H; Dieneman D; Dallenbach F; Delsol G; Minelli O; Poggi S; Martelli MF; Pallesen G
Hum Pathol; 1990 Jun; 21(6):624-9. PubMed ID: 1693592
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
3. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.
Schwarting R; Gerdes J; Dürkop H; Falini B; Pileri S; Stein H
Blood; 1989 Oct; 74(5):1678-89. PubMed ID: 2477085
[TBL] [Abstract][Full Text] [Related]
4. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.
Carbone A; Gloghini A; Volpe R
Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):527-32. PubMed ID: 1376944
[TBL] [Abstract][Full Text] [Related]
5. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features.
Kinney MC; Glick AD; Stein H; Collins RD
Am J Surg Pathol; 1990 Nov; 14(11):1047-60. PubMed ID: 2173429
[TBL] [Abstract][Full Text] [Related]
6. A6--a new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues.
Berti E; Aversa GG; Soligo D; Cattoretti G; Delia D; Aiello A; Parravicini C; Hall BM; Caputo R
Am J Clin Pathol; 1991 Feb; 95(2):188-93. PubMed ID: 1825147
[TBL] [Abstract][Full Text] [Related]
7. Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections.
Hansmann ML; Wacker HH; Gralla J; Lumbeck H; Kossmahl M; Heidebrecht HJ; Radzun HJ; Parwaresch MR
Blood; 1991 Feb; 77(4):809-17. PubMed ID: 1704265
[TBL] [Abstract][Full Text] [Related]
8. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.
Hauschild A; Sterry W
Am J Pathol; 1989 Jul; 135(1):177-84. PubMed ID: 2774058
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens.
Carbone A; Gloghini A; De Re V; Tamaro P; Boiocchi M; Volpe R
Cancer; 1990 Dec; 66(12):2547-56. PubMed ID: 2174301
[TBL] [Abstract][Full Text] [Related]
10. Expression of the low Mr isoform of CD45 (CD45RO) in B-cell non-Hodgkin's lymphomas.
Caldwell CW; Marty LM; Feldbush TL
Clin Immunol Immunopathol; 1991 Mar; 58(3):377-84. PubMed ID: 1825807
[TBL] [Abstract][Full Text] [Related]
11. The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45.
Terry LA; Brown MH; Beverley PC
Immunology; 1988 Jun; 64(2):331-6. PubMed ID: 2455685
[TBL] [Abstract][Full Text] [Related]
12. Antigen preservation in infarcted lymphoid tissue. A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues.
Norton AJ; Ramsay AD; Isaacson PG
Am J Surg Pathol; 1988 Oct; 12(10):759-67. PubMed ID: 3262314
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications.
Kinney MC; Greer JP; Glick AD; Salhany KE; Collins RD
Pathol Annu; 1991; 26 Pt 1():1-24. PubMed ID: 1849627
[TBL] [Abstract][Full Text] [Related]
14. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
Perkins PL; Ross CW; Schnitzer B
Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
[TBL] [Abstract][Full Text] [Related]
15. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).
Pileri S; Falini B; Delsol G; Stein H; Baglioni P; Poggi S; Martelli MF; Rivano MT; Mason DY; Stansfeld AG
Histopathology; 1990 Apr; 16(4):383-91. PubMed ID: 2163351
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
[TBL] [Abstract][Full Text] [Related]
17. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
18. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
19. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
Caldwell CW; Patterson WP
Am J Hematol; 1991 Feb; 36(2):111-5. PubMed ID: 1849347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
